NCT05356039Recruiting
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 30 Nov 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 28 Mar 2022
- Start date
- 19 Apr 2022
- Primary completion date
- May 2025
- Lead sponsor
- Umeå University
- Diseases
- Pancreatic cancer
- NCT number
- NCT05356039
What you commit to
- Study type: Observational
- Planned participants: 300
- From 19 Apr 2022 to the primary completion date, May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental or organic disorder interfering with informed consent or treatments
Age
- Age \< 18 years
Other
- Suspected endocrine tumor
- Suspected non-pancreatic periampullary tumor
- Distant metastasis
- Patient unable to understand verbal or written information interfering with informed consent or treatment
Who the study is looking for
- Confirmed or suspected invasive pancreatic primary tumor
- Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Surgical Clinic at Umeå University Hospital Coordinator of this site? Confirm its status | Umeå | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.